JP2021517116A5 - - Google Patents
Info
- Publication number
- JP2021517116A5 JP2021517116A5 JP2020545770A JP2020545770A JP2021517116A5 JP 2021517116 A5 JP2021517116 A5 JP 2021517116A5 JP 2020545770 A JP2020545770 A JP 2020545770A JP 2020545770 A JP2020545770 A JP 2020545770A JP 2021517116 A5 JP2021517116 A5 JP 2021517116A5
- Authority
- JP
- Japan
- Prior art keywords
- lymphoma
- alkyl
- heterocyclyl
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862646314P | 2018-03-21 | 2018-03-21 | |
| US62/646,314 | 2018-03-21 | ||
| PCT/US2019/023172 WO2019183226A1 (en) | 2018-03-21 | 2019-03-20 | Combination therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021517116A JP2021517116A (ja) | 2021-07-15 |
| JP2021517116A5 true JP2021517116A5 (https=) | 2022-03-28 |
Family
ID=67988025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545770A Pending JP2021517116A (ja) | 2018-03-21 | 2019-03-20 | 併用療法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20210000838A1 (https=) |
| EP (1) | EP3768258A4 (https=) |
| JP (1) | JP2021517116A (https=) |
| KR (1) | KR20200135439A (https=) |
| CN (1) | CN112165939A (https=) |
| AU (1) | AU2019238207A1 (https=) |
| BR (1) | BR112020019082A2 (https=) |
| CA (1) | CA3093847A1 (https=) |
| EA (1) | EA202092154A1 (https=) |
| IL (1) | IL277336A (https=) |
| MA (1) | MA52090A (https=) |
| MX (1) | MX2020009773A (https=) |
| SG (1) | SG11202009137PA (https=) |
| TW (1) | TW202002983A (https=) |
| WO (1) | WO2019183226A1 (https=) |
| ZA (1) | ZA202005661B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI572599B (zh) | 2011-03-28 | 2017-03-01 | Ｍｅｉ製藥公司 | （α－經取代之芳烷胺基及雜芳烷胺基）嘧啶基及１，３，５－三基苯并咪唑，其醫藥組合物及其在治療增生性疾病之用途 |
| CN112552401B (zh) | 2013-09-13 | 2023-08-25 | 广州百济神州生物制药有限公司 | 抗pd1抗体及其作为治疗剂与诊断剂的用途 |
| CN106604742B (zh) | 2014-07-03 | 2019-01-11 | 百济神州有限公司 | 抗pd-l1抗体及其作为治疗剂及诊断剂的用途 |
| WO2018033853A2 (en) | 2016-08-16 | 2018-02-22 | Beigene, Ltd. | Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof |
| WO2018033135A1 (en) | 2016-08-19 | 2018-02-22 | Beigene, Ltd. | Use of a combination comprising a btk inhibitor for treating cancers |
| US11304953B2 (en) | 2017-05-23 | 2022-04-19 | Mei Pharma, Inc. | Combination therapy |
| EP3645569A4 (en) | 2017-06-26 | 2021-03-24 | BeiGene, Ltd. | IMMUNOTHERAPY FOR LIVER CELL CARCINOMA |
| KR20200041358A (ko) | 2017-08-14 | 2020-04-21 | 메이 파마, 아이엔씨. | 병용 요법 |
| WO2019108795A1 (en) | 2017-11-29 | 2019-06-06 | Beigene Switzerland Gmbh | Treatment of indolent or aggressive b-cell lymphomas using a combination comprising btk inhibitors |
| CN113950327A (zh) * | 2019-06-10 | 2022-01-18 | 百济神州瑞士有限责任公司 | 口服胶囊剂及其制备方法 |
| US20220249491A1 (en) | 2019-06-10 | 2022-08-11 | Beigene Switzerland Gmbh | Oral solid tablet comprising bruton's tyrosine kinase inhibitor and preparation method therefor |
| CN110922409A (zh) * | 2019-12-19 | 2020-03-27 | 武汉九州钰民医药科技有限公司 | 制备btk抑制剂泽布替尼的方法 |
| KR20210115375A (ko) * | 2020-03-12 | 2021-09-27 | 보령제약 주식회사 | Pi3 키나아제 저해제 및 btk 저해제를 포함하는 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI572599B (zh) * | 2011-03-28 | 2017-03-01 | Ｍｅｉ製藥公司 | （α－經取代之芳烷胺基及雜芳烷胺基）嘧啶基及１，３，５－三基苯并咪唑，其醫藥組合物及其在治療增生性疾病之用途 |
| EP2983670A4 (en) * | 2013-04-08 | 2017-03-08 | Pharmacyclics LLC | Ibrutinib combination therapy |
| CN105979948A (zh) * | 2013-12-05 | 2016-09-28 | 安塞塔制药公司 | Pi3k抑制剂和btk抑制剂的治疗组合 |
| US9949971B2 (en) * | 2014-06-17 | 2018-04-24 | Acerta Pharma B.V. | Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor and/or a JAK-2 inhibitor |
| TW201618774A (zh) * | 2014-08-11 | 2016-06-01 | 艾森塔製藥公司 | 使用ｂｔｋ抑制劑透過調變腫瘤微環境來治療實體腫瘤及其他疾病之方法 |
-
2019
- 2019-03-20 CN CN201980034008.0A patent/CN112165939A/zh active Pending
- 2019-03-20 AU AU2019238207A patent/AU2019238207A1/en not_active Abandoned
- 2019-03-20 MA MA052090A patent/MA52090A/fr unknown
- 2019-03-20 EA EA202092154A patent/EA202092154A1/ru unknown
- 2019-03-20 CA CA3093847A patent/CA3093847A1/en active Pending
- 2019-03-20 SG SG11202009137PA patent/SG11202009137PA/en unknown
- 2019-03-20 BR BR112020019082-9A patent/BR112020019082A2/pt not_active IP Right Cessation
- 2019-03-20 US US16/981,780 patent/US20210000838A1/en not_active Abandoned
- 2019-03-20 WO PCT/US2019/023172 patent/WO2019183226A1/en not_active Ceased
- 2019-03-20 JP JP2020545770A patent/JP2021517116A/ja active Pending
- 2019-03-20 KR KR1020207030110A patent/KR20200135439A/ko not_active Ceased
- 2019-03-20 MX MX2020009773A patent/MX2020009773A/es unknown
- 2019-03-20 EP EP19770484.4A patent/EP3768258A4/en not_active Withdrawn
- 2019-03-21 TW TW108109853A patent/TW202002983A/zh unknown
-
2020
- 2020-09-11 ZA ZA2020/05661A patent/ZA202005661B/en unknown
- 2020-09-14 IL IL277336A patent/IL277336A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021517116A5 (https=) | ||
| JP7519259B2 (ja) | ヌクレオシドプロドラッグを調製する方法 | |
| JP2021523159A5 (https=) | ||
| JP2020517616A5 (https=) | ||
| JP2013544846A5 (https=) | ||
| JP2020532542A5 (https=) | ||
| CN112154142A (zh) | 整合应激通路的调节剂 | |
| JP2023531709A5 (https=) | ||
| JP2020532529A5 (https=) | ||
| CN111918652A (zh) | 用于治疗eb病毒阳性的癌症的趋化因子受体调节剂 | |
| JP2022071077A5 (https=) | ||
| JP2020531414A5 (https=) | ||
| JP2024513494A5 (https=) | ||
| JP2013541586A5 (https=) | ||
| JP2011506402A5 (https=) | ||
| JP2016501838A5 (https=) | ||
| JP2021534114A5 (https=) | ||
| KR102904026B1 (ko) | 헤테로시클릭 단백질 키나제 억제제를 포함하는 제제 | |
| JP2020503376A5 (https=) | ||
| JP2023531495A5 (https=) | ||
| JPWO2020032105A5 (https=) | ||
| CA2652811C (en) | Potentiator of radiation therapy | |
| JP6422936B2 (ja) | ５−ブロモ−インジルビン | |
| JP2014521609A5 (https=) | ||
| JP2021534115A5 (https=) |